Huge congratulations to Oguzhan, David, and the exceptional BillionToOne team on securing $130 million in an oversubscribed Series D funding round. This funding will further revolutionize the prenatal screening and oncology diagnostics landscape.
Read MoreCongratulations to Mammoth Biosciences team for securing a $100M upfront gene-editing collaboration with Regeneron to develop in vivo gene-editing therapies for various tissues beyond the liver→
/
Mammoth and Regeneron will collaborate on in vivo CRISPR-based gene editing therapies in a deal worth $100 million upfront plus $370 million in milestones per target.
Read MoreCongratulations to Fauna Bio for signing a $494 million strategic collaboration deal with Eli Lilly to discover novel therapeutics for obesity→
/
Fauna Bio improving human health by leveraging animal genomics, today announced a multi-year agreement with Eli Lilly and Company to apply Fauna's Convergence™ artificial intelligence (AI) platform to support preclinical drug discovery efforts in obesity.
Read MoreInterface has secured $3 million in an oversubscribed seed funding round to advance its AI drug discovery platform for inflammatory disease→
/
Interface Bio emerges with $3m to harness the microbiome against inflammation. The AI-powered platform identifies bacterial natural products with the potential to modulate the immune system and reduce inflammation.
Read MoreBillionToOne launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use→
/
BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use
Read MoreBillionToOne secures additional $83.5M to accelerate growth and commercialize its Northstar Select and Northstar Response liquid biopsy tests in early 2023→
/
BillionToOne Secures $83.5M in Private Funding, Loan Facility; Shows Clinical Performance of NIPT
Read MoreCongratulations to Meliora Therapeutics for raising $11M seed financing round→
/
Bayer and Mammoth Biosciences today announced a strategic collaboration and option agreement for the use of Meliora Therapeutics Raises $11M Seed Financing to Develop First Mechanism Of Action Atlas in Oncology
Read MoreCongratulations to Mammoth Biosciences for signing a more than $1 billion collaboration agreement with Bayer to unlock the full potential of ultra-small CRISPR systems→
/
Bayer and Mammoth Biosciences today announced a strategic collaboration and option agreement for the use of Mammoth’s CRISPR systems to develop in vivo gene-editing therapies
Read MoreCongratulations to Mammoth Biosciences for signing a $691M collaboration deal with Vertex→
/
Vertex Pharmaceuticals and Mammoth Biosciences today announced a new partnership to develop in vivo gene-editing therapies for two genetic diseases using Mammoth’s next-generation CRISPR systems.
Read MoreCongratulations to Fauna Bio for raising $9M Seed financing→
/
Fauna Bio raises $9 Million to expand the comparative genomics platform for novel target discovery. This round is led by LifeForce Capital with participation from previous investors including Pacific 8 Ventures, True Ventures, and more.
Read MoreCongratulations to Mammoth Biosciences on $195 million financing at $1 billion+ valuation, led by Redmile Group and Foresite Capital→
/
Mammoth Biosciences raises $195 million, vaulting Its CRISPR tech to unicorn status. The latest round of financing will supercharge the creation of transformative CRISPR products including ultra-small proteins for therapeutics and decentralized diagnostics.
Read MoreCongratulations to Fauna Bio CTO, Linda Goodman for publishing in Nature with Broad Institute investigate around 110 million years of mammalian evolution→
/
Fauna Bio co-founder and Chief Technology Officer, Linda Goodman, is a co-author on a study published in Nature as part of an international team of researchers, which analyzed and compared the whole genomes of more than 80 percent of all mammalian families, spanning almost 110 million years of evolution.
Read MoreCongratulations to Mammoth Biosciences Co-founder Professor Jennifer Doudna for winning Nobel Prize in chemistry for CRISPR discovery→
/
Mammoth Biosciences Co-founder and Chair of the Scientific Advisory Board, Professor Jennifer Douda today won the Nobel Prize in Chemistry with colleague Professor Emmanuel Charpentier for their discovery of the genome editing tool CRISPR-Cas9. At Mammoth, Prof. Doudna continues to pioneer new Cas protein discoveries and applications across diagnostics and therapeutics and guide the company’s scientific vision.
Read MoreMammoth Biosciences collaborates with GSK Consumer Healthcare to develop at home COVID-19 test→
/
Mammoth Bioscience today announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use, fully disposable, rapid and handheld test that consumers and healthcare providers in clinics can use to detect active SARS-CoV-2, the novel coronavirus that causes COVID-19.
Read MoreCongratulations to Karius for securing $165MM Series B Funding, Led by Softbank Vision Fund 2→
/
Karius will expand access to its proprietary microbial cell-free DNA technology to help doctors diagnose infectious diseases, broaden clinical development, and accelerate technology innovation
Read More
Congratulations to Mammoth Biosciences for raising $45M Series B, led by Decheng Capital and new investor Verily→
/
Mammoth Biosciences today announced a $45M Series B to develop the next generation of CRISPR products and help to tackle Coronavirus.
Read More
Congratulations to FaunaBio CSO Katharine Grabek for her publication in Nature Communication Biology!→
/
Her landmark paper in Nature Communications Biology around associating genetic variants with the onset of hibernation and identifying changes related to food intake, insulin signaling, and heart rate.
Read more (Article review from Stanford) —>
Read MoreCongratulations to BillionToOne for launching UNITY™ prenatal screen→
/
Powered by BillionToOne's patent-pending molecular counting technology, UNITY is the only prenatal screen that tests cell-free fetal DNA for cystic fibrosis, spinal muscular atrophy (SMA) and sickle cell disease using just one tube of blood from the mother. https://unityscreen.com/
Read More —>
Read More